Company Performance Metrics
Daniela Monaco: CSO- Jorge Eloy Alan Atala: Founder and CTO
Sequegenics is a biotechnology company developing next-generation multi-omics solutions that combine long-read genome and transcriptome sequencing with proteomics, and AI-powered analytics to uncover hidden layers of biology. Our proprietary technology enables high-throughput, high-resolution data generation that captures complex genetic signatures
often missed by conventional approaches. By integrating these rich datasets into a unified analysis platform, we deliver unique insights into biological systems — accelerating target discovery, improving disease modeling, and powering the development of high-value therapeutic assets. With applications across drug discovery, rare disease research, and precision medicine, Sequegenics is building a scalable engine to transform biological complexity into actionable intelligence.
